OBJECTIVE: HIV infection is an established risk for diarrhoeal severity, less is known about specific enteric pathogens associated with HIV status. We determined associations of selected enteric pathogens with HIV infection and HIV exposure among Kenyan children. DESIGN: A cross-sectional study among 6 months to 15 year olds presenting to two Western Kenya District hospitals with acute diarrhoea between 2011 and 2013. METHODS: Stool was tested using standard bacterial culture and microscopy for ova and parasites. HIV status was obtained from children and mothers. Enteric pathogen prevalence was compared between HIV-infected and HIV-uninfected children and between HIV-exposed uninfected (HEU) and HIV-unexposed. Unadjusted and adjusted prevalence ratios for selected pathogens by HIV status were estimated using relative risk (RR) regression. Age, site, income, household crowding, water source/treatment, anthropometrics, cotrimoxazole use and breastfeeding history were accounted for in multivariable models. RESULTS: Among 1076 children, median age was 22 months (interquartile range: 11-42 months), 56 (5.2%) were HIV-infected and 105 (11.3%) of 926 HIV-uninfected children in whom maternal HIV status was obtained were HIV-exposed. The following organisms were most frequently isolated from stool: enteroaggregative Escherichia coli (13.3%), Giardia species (spp.) (11.1%), Campylobacter spp. (6.3%), enteropathogenic E. coli (EPEC) (6.1%) and Cryptosporidium spp. (3.7%). Accounting for age, HIV-infection was associated with typical EPEC infection (prevalence ratio 3.70, P = 0.002) while HIV-exposure was associated with Cryptosporidium among HIV-uninfected children (prevalence ratio 2.81, P = 0.005). CONCLUSION: EPEC and Cryptosporidium infections were more common in HIV-infected and HIV-exposed children, respectively. This could explain the increased mortality attributed to these pathogens in other studies. Interventions targeting EPEC and Cryptosporidium may reduce morbidity and mortality in high HIV-prevalence settings.
OBJECTIVE:HIV infection is an established risk for diarrhoeal severity, less is known about specific enteric pathogens associated with HIV status. We determined associations of selected enteric pathogens with HIV infection and HIV exposure among Kenyan children. DESIGN: A cross-sectional study among 6 months to 15 year olds presenting to two Western Kenya District hospitals with acute diarrhoea between 2011 and 2013. METHODS: Stool was tested using standard bacterial culture and microscopy for ova and parasites. HIV status was obtained from children and mothers. Enteric pathogen prevalence was compared between HIV-infected and HIV-uninfectedchildren and between HIV-exposed uninfected (HEU) and HIV-unexposed. Unadjusted and adjusted prevalence ratios for selected pathogens by HIV status were estimated using relative risk (RR) regression. Age, site, income, household crowding, water source/treatment, anthropometrics, cotrimoxazole use and breastfeeding history were accounted for in multivariable models. RESULTS: Among 1076 children, median age was 22 months (interquartile range: 11-42 months), 56 (5.2%) were HIV-infected and 105 (11.3%) of 926 HIV-uninfectedchildren in whom maternal HIV status was obtained were HIV-exposed. The following organisms were most frequently isolated from stool: enteroaggregative Escherichia coli (13.3%), Giardia species (spp.) (11.1%), Campylobacterspp. (6.3%), enteropathogenic E. coli (EPEC) (6.1%) and Cryptosporidiumspp. (3.7%). Accounting for age, HIV-infection was associated with typical EPEC infection (prevalence ratio 3.70, P = 0.002) while HIV-exposure was associated with Cryptosporidium among HIV-uninfectedchildren (prevalence ratio 2.81, P = 0.005). CONCLUSION: EPEC and Cryptosporidiuminfections were more common in HIV-infected and HIV-exposed children, respectively. This could explain the increased mortality attributed to these pathogens in other studies. Interventions targeting EPEC and Cryptosporidium may reduce morbidity and mortality in high HIV-prevalence settings.
Authors: Breyette Lorntz; Alberto M Soares; Sean R Moore; Relana Pinkerton; Bruce Gansneder; Victor E Bovbjerg; Helen Guyatt; Aldo M Lima; Richard L Guerrant Journal: Pediatr Infect Dis J Date: 2006-06 Impact factor: 2.129
Authors: James K Tumwine; Addy Kekitiinwa; Sabrina Bakeera-Kitaka; Grace Ndeezi; Robert Downing; Xiaochuan Feng; Donna E Akiyoshi; Saul Tzipori Journal: Am J Trop Med Hyg Date: 2005-11 Impact factor: 2.345
Authors: Sean R Moore; Noélia L Lima; Alberto M Soares; Reinaldo B Oriá; Relana C Pinkerton; Leah J Barrett; Richard L Guerrant; Aldo A M Lima Journal: Gastroenterology Date: 2010-06-02 Impact factor: 22.682
Authors: Gerald T Keusch; Irwin H Rosenberg; Donna M Denno; Christopher Duggan; Richard L Guerrant; James V Lavery; Philip I Tarr; Honorine D Ward; Robert E Black; James P Nataro; Edward T Ryan; Zulfiqar A Bhutta; Hoosen Coovadia; Aldo Lima; Balakrishnan Ramakrishna; Anita K M Zaidi; Deborah C Hay Burgess; Thomas Brewer Journal: Food Nutr Bull Date: 2013-09 Impact factor: 2.069
Authors: Li Liu; Hope L Johnson; Simon Cousens; Jamie Perin; Susana Scott; Joy E Lawn; Igor Rudan; Harry Campbell; Richard Cibulskis; Mengying Li; Colin Mathers; Robert E Black Journal: Lancet Date: 2012-05-11 Impact factor: 79.321
Authors: Alana T Brennan; Rachael Bonawitz; Christopher J Gill; Donald M Thea; Mary Kleinman; Lawrence Long; Caitryn McCallum; Matthew P Fox Journal: J Acquir Immune Defic Syndr Date: 2019-09-01 Impact factor: 3.731
Authors: Matthew A Hulverson; Sumiti Vinayak; Ryan Choi; Deborah A Schaefer; Alejandro Castellanos-Gonzalez; Rama S R Vidadala; Carrie F Brooks; Gillian T Herbert; Dana P Betzer; Grant R Whitman; Hayley N Sparks; Samuel L M Arnold; Kasey L Rivas; Lynn K Barrett; A Clinton White; Dustin J Maly; Michael W Riggs; Boris Striepen; Wesley C Van Voorhis; Kayode K Ojo Journal: J Infect Dis Date: 2017-04-15 Impact factor: 5.226
Authors: Irene N Njuguna; Lisa M Cranmer; Anjuli D Wagner; Sylvia M LaCourse; Cyrus Mugo; Sarah Benki-Nugent; Barbra A Richardson; Joshua Stern; Elizabeth Maleche-Obimbo; Dalton C Wamalwa; Grace John-Stewart Journal: J Acquir Immune Defic Syndr Date: 2019-06-01 Impact factor: 3.731
Authors: Patricia B Pavlinac; Rebecca L Brander; Hannah E Atlas; Grace C John-Stewart; Donna M Denno; Judd L Walson Journal: BMC Public Health Date: 2018-02-01 Impact factor: 3.295
Authors: P B Pavlinac; D M Denno; G C John-Stewart; F M Onchiri; J M Naulikha; E A Odundo; C E Hulseberg; B O Singa; L E Manhart; J L Walson Journal: J Pediatric Infect Dis Soc Date: 2015-07-12 Impact factor: 3.164
Authors: Kirsten Fagerli; Laura Gieraltowski; Benjamin Nygren; Eric Foote; Joanna Gaines; Jared Oremo; Aloyce Odhiambo; Sunkyung Kim; Robert Quick Journal: Am J Trop Med Hyg Date: 2020-04-02 Impact factor: 2.345
Authors: Aline Dupont; Felix Sommer; Kaiyi Zhang; Urska Repnik; Marijana Basic; André Bleich; Mark Kühnel; Fredrik Bäckhed; Yael Litvak; Marcus Fulde; Ilan Rosenshine; Mathias W Hornef Journal: PLoS Pathog Date: 2016-05-09 Impact factor: 6.823